The Inflation Reduction Act (IRA) changes the way Medicare pays for prescription drugs. These changes will impact various stakeholders, including Medicare, Medicare enrollees, drug manufacturers, and others.
Office of Health Policy (HP)
The Office of Health Policy (HP) provides a cross-cutting perspective that bridges Departmental programs, state, local, and private sector activities, and the research community, in order to develop, analyze, coordinate and inform leadership on health policy issues for the Secretary. HP carries out this mission by conducting policy and economic and budget analyses, assisting in the development and review of regulations, budgets, legislation, and survey design efforts, as well as conducting and coordinating research, evaluation, and information dissemination on issues relating to health policy.
HP is organized in four divisions that align with major Department programs:
Division of Health Care Financing Policy (HFP)
Division of Public Health Services (PHS)
Division of Health Care Quality and Outcomes (HQO)
Division of Health Care Access and Coverage (HAC)
Health Policy Research:
- Reports to Congress
- Research & Issue Briefs
- HP Authored or Sponsored Work Published in Journals
Other Helpful Information:
Topic Areas:
- Children's Health Insurance Program (CHIP)
- Data
- Evaluation
- Health & Health Care
- Health Indicators
- Health Care Coverage and Access
- Health Policy
- Healthcare Reform
- Healthcare Safety Net
- HIV & AIDS
- Medicaid
- Medicare
- Patient-Centered Outcomes Research Trust Fund (PCORTF)
- Prescription Drugs & Other Medical Products
- Public Health
- Uninsured & Underinsured
Contact Us: ASPEHealthPolicy@hhs.gov
Reports
Displaying 11 - 20 of 542. 10 per page. Page 2.
Advanced SearchASPE Issue Brief, Report
An Evaluation Framework for the Inflation Reduction Act’s Medicare Prescription Drug Related Provisions
A Framework for Evaluating the Impact of the Center for Medicare and Medicaid Innovation
This ASPE issue brief lays out a proposed comprehensive analytic framework to fully evaluate the impact of the CMS Innovation Center’s efforts on the Medicare program and the broader health care system as a whole to test innovative payment and service delivery models that reduce program expenditures while preserving or enhancing the quality of care.
ASPE Issue Brief
Trends in Medicaid and CHIP Telehealth, 2019-2021 Part II: Medicaid and CHIP Telehealth Utilization Trends by Enrollee and Provider Rurality
During the pandemic period, telehealth utilization increased among both urban and rural enrollees in Medicaid, with urban enrollees sustaining greater gains in telehealth utilization at the end of 2021. This Issue Brief is part of a series of ASPE Issue Briefs examining changes in Medicaid utilization of services delivered via telehealth by enrollee and provider characteristics.
Report
Estimating the Effects of the Medicare $2 Drug List on Part D Enrollees
The Centers for Medicare & Medicaid Services (CMS) Innovation Center is in the process of developing the Medicare $2 Drug List (M2DL) Model. This would allow Part D plan sponsors to offer a standardized list of generic drugs for a copayment of $2 or less for a month’s supply that would not be subject to prior authorization, quantity limits, or other utilization management restrictions.
Report to Congress
No Surprises Act Drug Pricing Report to Congress
Prescription drug prices are a top concern for policymakers and the public, but little data is available on prescription drug prices or other costs that contribute to premiums for commercial drug coverage.
ASPE Issue Brief
Medicare Coverage of Anti-Obesity Medications
In November 2024, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Program; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
Report, Report to Congress
Evaluation of the Impact of the No Surprises Act on Health Care Market Outcomes: Exploring Pre-Implementation Trends - Report Two
This second report focuses largely on updating pre-NSA trends in claims data presented in the first report.
ASPE Data Point
Evaluating Medicaid Strategies to Streamline Ex Parte Renewals
National estimates indicate that streamlined renewal options for Medicaid beneficiaries with incomes below 100 percent of the federal poverty level and without an ex parte income data source would provide timely and accurate eligibility determinations.
Report
Feasibility of Obtaining Identifiers for Self-Directing Home and Community-Based Services Users in Medicaid Claims
This report outlines a feasibility study focused on obtaining identifiers for self-directed Home and Community-Based Services (HCBS) users within Medicaid claims data. Financial Management Services (FMS) entities assist individuals in managing the financial aspects of self-directed care, including payroll and billing.
Database, Dataset
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2023 American Community Survey
In order to support state and local outreach efforts, ASPE has developed state, county, and local estimates of the number of U.S. residents without health insurance and their demographic characteristics, using the most recent Census data available from the 2023 American Community Survey (ACS).